Compare ALLT & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALLT | CYRX |
|---|---|---|
| Founded | 1996 | 1999 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 429.1M | 472.7M |
| IPO Year | 2006 | N/A |
| Metric | ALLT | CYRX |
|---|---|---|
| Price | $9.80 | $9.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | $12.75 | ★ $12.83 |
| AVG Volume (30 Days) | 401.2K | ★ 464.7K |
| Earning Date | 11-20-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | 0.02 | ★ 1.27 |
| Revenue | $98,512,000.00 | ★ $243,795,000.00 |
| Revenue This Year | $12.08 | N/A |
| Revenue Next Year | $12.38 | $9.26 |
| P/E Ratio | $456.22 | ★ $7.60 |
| Revenue Growth | 7.51 | ★ 41.27 |
| 52 Week Low | $4.37 | $4.58 |
| 52 Week High | $11.42 | $11.44 |
| Indicator | ALLT | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 57.35 | 53.55 |
| Support Level | $9.06 | $9.40 |
| Resistance Level | $9.95 | $9.95 |
| Average True Range (ATR) | 0.40 | 0.34 |
| MACD | 0.05 | -0.00 |
| Stochastic Oscillator | 67.71 | 52.83 |
Allot Ltd is a provider of network intelligence and security solutions for service providers and enterprises. The company's solutions are deployed globally for network and application analytics, traffic control and shaping, and network-based security services. The firm's multi-service platforms are deployed by mobile, fixed, and cloud service providers and enterprises. The company has a customer base in Europe, Asia and Oceania, the Americas, the Middle East, and Africa.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.